Gastrointestinal cancers can be complex. Dr. Bedi's multidisciplinary approach ensures nothing is overlooked and every decision is made with you, not for you.
GI cancers affect the digestive system — stomach, colon, rectum, pancreas, liver, oesophagus, and gallbladder. They're among the most common cancers in India, often linked to diet, lifestyle, infection (H. pylori, Hepatitis B/C), or genetics. Accurate diagnosis and staging are critical.
GI cancers require close collaboration between medical, surgical, and radiation oncology. Dr. Bedi coordinates your entire treatment through Fortis's multidisciplinary tumour board.
Whether chemo comes before or after surgery matters enormously. The tumour board determines the optimal order for your case.
Modern protocols combine chemotherapy with targeted therapies that block specific growth pathways.
For cancers with microsatellite instability, immunotherapy has become a game-changer.
Digestive cancers affect nutrition. Dr. Bedi's team includes dietitians who help maintain your strength.
GI cancers can feel daunting because they affect something fundamental — how you eat, how you feel daily. But we have effective treatments, we have a plan, and you're never navigating this alone.
Stomach and colorectal cancer are most prevalent, followed by liver and gallbladder cancer — particularly in North India.
Early-stage GI cancers have excellent cure rates. Even advanced cases can often be controlled for extended periods with modern treatment.
Diets high in processed meats and smoked foods increase risk. Fibre-rich diets are protective. Dr. Bedi's team provides dietary guidance.
Many GI cancers benefit from combination treatment. The tumour board determines the best sequence for you.
Dr. Bedi and his team are here to listen, answer your questions, and build a path forward — together.